Proteomics

  • The microfluidic component market dominated by polymer-based microfluidics, glass-based microfluidics, silicone-based microfluidics, and other material-based microfluidics. The polymer-based microfluidics accounted for the largest share of the market.

  • MarketReportsOnline.com adds "Europe Proteomics Market Forecast 2019-2027" report to its research store.

  • Geographically, global microfluidics market is segmented into North America, Europe, Asia Pacific, Latin America, & Middle East and Africa. North America holds largest share of this market in 2017. Compared to Europe & Asia Pacific, North America has various additional advantages such as investment initiatives by government and presence of high-quality infrastructure for clinical and laboratory research.

  • Top Key Players in the Proteomics Market include are Thermo Fisher Scientific, Inc. (US), Agilent Technologies,Inc.(US),GE Healthcare (US), Bio-Rad Laboratories,Inc. (US), Danaher Corporation (US), Luminex Corporation (US), Bruker Corporation (US),Merck KGaA,(Germany), Waters Corporation (US), PerkinElmer,Inc. (US), Creative Proteomics (US), and Promega Corporation (US).

  • Report analyzes microfluidics market & aims at estimating market size & future growth potential of this market based on various segments such as application, component, material, & region. The microfluidics market report provides practical application of small fluid volumes for design of systems and development of solutions. The regulatory standards consume too much time for the approval process of microfluidics devices.

  • Report analyzes microfluidics market by application, component, material, and region. Based on application, market is segmented into in vitro diagnostics, pharmaceutical and life science research, drug delivery, & laboratory testing.

  • Asia Pacific is expected to account for the highest growth of the bioinformatics market by 2023, followed by North America. The high growth of Asia Pacific market is primarily attributed to rising penetration of cutting-edge research and clinical laboratory technologies and increasing public- and private-sector investments in genomics, proteomics, and related technologies.

  • The Proteomics Market Report provides critical data of Production, Supply, Sales, Demand, Market Status and Industry Development Trend of Proteomics Market. This Report is a Result of best research material, competitive landscape analysis that will help Decision makers to excel based on futuristic chart.

  • The microfluidics market is projected to reach USD 27.91 billion by 2023 from estimated USD 10.06 billion in 2018, at a CAGR of 22.6%. Quick returns on investment coupled with the fast results and improved portability of the medical equipment embedded with microfluidics technology are the factors expected to drive the market during the forecast period.

  • The proteomics market is broadly segmented into protein microarray, spectroscopy, X-ray crystallography, chromatography, electrophoresis, surface plasmon resonance (SPR) systems, and protein fractionation systems. In 2015, the spectroscopy segment accounted for the largest share of the proteomics market.

  • Prominent players in the global bioinformatics services market included Eurofins Scientific (Luxembourg), BGI (China), NeoGenomics (US), PerkinElmer (US), CD Genomics (US), Macrogen (South Korea), QIAGEN (Germany), GENEWIZ (US), Source BioScience (UK), Microsynth (Switzerland), MedGenome (India), Fios Genomics (UK), and BaseClear (Netherlands), among others.

  • Sample preparation market is poised to reach USD 7,203.2 Million by 2021 from USD 5,512.2 Million in 2016, growing at a CAGR of 5.5% to 2021. Sample preparation involves conversion of samples into a format which can be directly placed in analytical instruments for analysis. Conversion process ranges from simple ‘dilute and shoot’ methods to complex multi-stage sample handling activities.

  • The global liquid handling systems market expected to reach USD 3.74 billion by 2022, at a CAGR of 7.2%. Rapidly developing global biotechnology & pharmaceutical industries, rising requirement for high-throughput screening (HTS), increasing emphasis on data precision and accuracy, and technological innovations are major factors driving this market.